Research Topic · Peer-Reviewed

Hydroxychloroquine

Hydroxychloroquine is a medication that has received significant attention due to the COVID-19 pandemic. It is a drug that has been traditionally used for the treatment of malaria, autoimmune diseases like Rheumatoid Arthritis and Lupus, and several other ailments. Due to its potential role in preventing the sympto…

Curated from this journal's research 📚 4 peer-reviewed articles cited Cited 4× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

Hydroxychloroquine is a medication that has received significant attention due to the COVID-19 pandemic. It is a drug that has been traditionally used for the treatment of malaria, autoimmune diseases like Rheumatoid Arthritis and Lupus, and several other ailments. Due to its potential role in preventing the symptoms of COVID-19, Hydroxychloroquine has become an important medication in the fight against the ongoing pandemic. The drug has been found to inhibit the replication of coronavirus, making it a potential candidate for the treatment of COVID-19. Several clinical studies have been conducted to test the efficacy and safety of Hydroxychloroquine in the treatment of COVID-19. While some studies suggest that it may be beneficial in reducing the progression of the disease, others have reported no significant benefits. It is important to note that Hydroxychloroquine should only be used in accordance with the recommendation of a healthcare provider. Moreover, it has been associated with several side effects, including gastrointestinal discomfort, skin rashes, and blurred vision. In conclusion, Hydroxychloroquine has emerged as an important medication in the fight against the COVID-19 pandemic. While it has been shown to have some efficacy in reducing the progression of the disease, further studies are required to determine its safety and efficacy as a COVID-19 treatment.

Research published in this journal

4 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 4 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Hydroxychloroquine, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.